Year-end Sale % OFF 
Abstract
Research suggests that daily cannabis users have impaired memory for past events, but it is not clear whether they are also impaired in prospective memory (PM) for future events. The present study examined PM in daily cannabis users who were either dependent (n = 18) or non-dependent (n = 18), and compared them with non-using controls (n = 18). The effect of future event simulation (FES) on PM performance was also examined. Participants were matched across groups on age, gender, and highest level of education. The virtual week (VW) was used to objectively assess PM abilities, both at baseline and following FES. Other measures used were: cannabis use variables, immediate and delayed prose recall, phonemic and category fluency, spot-the-word test (premorbid intelligence), Beck Depression Inventory, Beck Anxiety Inventory, and a measure of schizotypy (Oxford-Liverpool Inventory of Feelings and Experiences: unusual experiences subscale). No group differences were found in PM performance on the VW, and FES did not improve PM performance in any group. Dependent cannabis users scored higher on depression, anxiety, and schizotypy than both other groups with non-dependent cannabis users scoring at a similar level to controls. There were no group differences in alcohol use. Findings suggest that when carefully matched on baseline variables, and not differing in premorbid IQ or alcohol use, young, near-daily cannabis users do not differ from non-using controls in PM performance.
Highlights
Cannabis has consistently been the most commonly consumed illicit drug in the world, with an estimated 120–190 million users worldwide [1]
When carefully matched on key demographic variables, including educational level and alcohol use, and when dependent and non-dependent users did not differ on any cannabis use variable, we found no evidence for a PM deficit in young adults in any group, nor evidence that FES has any effect on performance
The two cannabis groups differed significantly in cannabis dependence, and on scores of depression, anxiety, and schizotypy
Summary
Cannabis has consistently been the most commonly consumed illicit drug in the world, with an estimated 120–190 million users worldwide [1]. It is increasingly becoming a legal drug for medical and/or recreational use in many parts of the globe and its use is increasing [1]. Frequent cannabis use has been associated with depression and anxiety [2]. Higher rates of depression and anxiety have been observed in frequent users who are dependent on cannabis compared with frequent users who are non-dependent, who score to the general population [3]. There is an association between use of high-potency cannabis and psychosis [4]
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
